Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer

Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer

The addition of trastuzumab to chemotherapy was demonstrated to be beneficial for advanced human epidermal growth factor receptor-2 (HER-2) positive gastric cancer. However, the HER-2 status of rectal cancer remains uncertain. This study aimed to determine the HER-2 expression in a large multicenter...

Full description

Bibliographic Details
Main Authors: Meng, Xiangjiao, Huang, Zhaoqin, Di, Jian, Mu, Dianbin, Wang, Yawei, Zhao, Xianguang, Zhao, Hanxi, Zhu, Wanqi, Li, Xiaolin, Kong, Lingling, Xing, Ligang
Format: Online
Language:English
Published: Wolters Kluwer Health 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058996/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058996/

Similar Items